T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Edwards Lifesciences
EW
$53.4B
| $62.8M | 0.01% |
1,081,344
-30,366
| -3% | -$1.49M |
|
827
Freeport-McMoran
FCX
$93.6B
| $62.7M | 0.01% |
4,505,824
+835,977
| +23% | +$12.6M |
|
828
Assured Guaranty
AGO
$3.35B
| $62.5M | 0.01% |
1,479,107
-33,279
| -2% | -$1.32M |
|
829
Nasdaq
NDAQ
$54.6B
| $62.2M | 0.01% |
2,174,235
-1,484,634
| -41% | -$45.7M |
|
|
STMP
830
DELISTED
Stamps.com, Inc.
STMP
| $62.1M | 0.01% |
274,567
+3,742
| +1% | +$936K |
|
|
ACBI
831
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $62M | 0.01% |
3,700,352
+29,513
| +0.8% | +$545K |
|
|
BERY
832
DELISTED
Berry Global Group, Inc.
BERY
| $61.9M | 0.01% |
1,393,910
+22,435
| +2% | +$986K |
|
|
ZGNX
833
DELISTED
Zogenix, Inc.
ZGNX
| $61.9M | 0.01% |
1,247,626
+172,381
| +16% | +$8.78M |
|
834
Allstate
ALL
$65.9B
| $61.8M | 0.01% |
626,551
-15,849
| -2% | -$1.55M |
|
835
Texas Roadhouse
TXRH
$13.6B
| $61.8M | 0.01% |
891,333
+163,149
| +22% | +$11.1M |
|
836
Ford
F
$55.4B
| $61M | 0.01% |
6,592,039
-105,100
| -2% | -$1.05M |
|
837
PTC
PTC
$16.7B
| $60.8M | 0.01% |
572,620
-15,500
| -3% | -$1.51M |
|
838
Exelixis
EXEL
$12.5B
| $60.8M | 0.01% |
3,431,376
-1,402,102
| -29% | -$27.3M |
|
839
Dorman Products
DORM
$3.95B
| $60.6M | 0.01% |
787,773
-11,250
| -1% | -$860K |
|
840
TransDigm Group
TDG
$68.9B
| $60.4M | 0.01% |
162,305
+4,336
| +3% | +$1.56M |
|
|
RAVN
841
DELISTED
Raven Industries Inc
RAVN
| $60.1M | 0.01% |
1,313,892
-9,286
| -0.7% | -$395K |
|
842
Helen of Troy
HELE
$699M
| $59.9M | 0.01% |
457,933
+8,234
| +2% | +$970K |
|
843
Travelers Companies
TRV
$77.2B
| $59.9M | 0.01% |
462,078
-16,811
| -4% | -$2.17M |
|
844
Encompass Health
EHC
$12.2B
| $59.9M | 0.01% |
966,407
+347,606
| +56% | +$21.1M |
|
845
Casella Waste Systems
CWST
$5.79B
| $59.9M | 0.01% |
1,927,131
+37,578
| +2% | +$1.07M |
|
|
ISBC
846
DELISTED
Investors Bancorp, Inc.
ISBC
| $59.8M | 0.01% |
4,877,417
+94,964
| +2% | +$1.21M |
|
|
FOCS
847
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $59.7M | 0.01% |
+1,257,101
| New | +$53.7M |
|
848
UFP Industries
UFPI
$5.03B
| $59.5M | 0.01% |
1,685,307
+45,099
| +3% | +$1.66M |
|
|
WRI
849
DELISTED
Weingarten Realty Investors
WRI
| $59.3M | 0.01% |
1,993,298
-266,762
| -12% | -$8.1M |
|
850
Exponent
EXPO
$3.24B
| $59M | 0.01% |
1,101,610
+20,274
| +2% | +$1.04M |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.